Trial Information

Summary: Do you have diabetes?

You may be eligible to participate in a research study of an investigational inhaled insulin.
Today, local doctors are conducting a medical research study to evaluate whether a new cutting-edge procedure for delivering insulin can be used safely and effectively as treatment for diabetes.

You may qualify if you...

  • Have been diagnosed with Type 2 Diabetes for at least 2 years.
  • Are currently receiving a Pre-/Self Mixed Insulin Therapy 2 to 3 times daily.
  • Are a Non-Smoking Male or Female between the ages of 18 and 80.

Qualified participants may receive...

  • Study-related medical care
  • No cost expert advice about their diabetes care
  • Laboratory work and evaluations
  • Study medication

...All at No Cost.
To learn if you are eligible to participate, talk with your doctor, or for more information,

Contact:

Montana Health Research Institute, Inc.
2101 Broadwater Ave.
Billings, MT 59102
Telephone: 406-652-6630 or 888-802-6080
Email:

Profile Page: Montana Health Research Institute, Inc., Billings, MT

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:46:15 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA